U.S. markets open in 6 hours 6 minutes
  • S&P Futures

    4,130.00
    +23.00 (+0.56%)
     
  • Dow Futures

    34,105.00
    +167.00 (+0.49%)
     
  • Nasdaq Futures

    13,197.50
    +97.25 (+0.74%)
     
  • Russell 2000 Futures

    2,184.30
    +15.70 (+0.72%)
     
  • Crude Oil

    63.88
    +0.06 (+0.09%)
     
  • Gold

    1,833.50
    +9.50 (+0.52%)
     
  • Silver

    27.33
    +0.27 (+0.98%)
     
  • EUR/USD

    1.2120
    +0.0035 (+0.29%)
     
  • 10-Yr Bond

    1.6680
    0.0000 (0.00%)
     
  • Vix

    23.13
    -4.46 (-16.17%)
     
  • GBP/USD

    1.4063
    +0.0011 (+0.08%)
     
  • USD/JPY

    109.3830
    -0.0510 (-0.05%)
     
  • BTC-USD

    49,785.45
    -1,292.78 (-2.53%)
     
  • CMC Crypto 200

    1,375.22
    -12.69 (-0.91%)
     
  • FTSE 100

    7,006.71
    +43.38 (+0.62%)
     
  • Nikkei 225

    28,084.47
    +636.46 (+2.32%)
     

What Kind Of Investor Owns Most Of Bioanalytical Systems, Inc. (NASDAQ:BASI)?

Simply Wall St

The big shareholder groups in Bioanalytical Systems, Inc. (NASDAQ:BASI) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. I generally like to see some degree of insider ownership, even if only a little. As Nassim Nicholas Taleb said, 'Don’t tell me what you think, tell me what you have in your portfolio.'

Bioanalytical Systems is not a large company by global standards. It has a market capitalization of US$22m, which means it wouldn't have the attention of many institutional investors. Taking a look at our data on the ownership groups (below), it's seems that institutions are noticeable on the share registry. Let's delve deeper into each type of owner, to discover more about BASI.

Check out our latest analysis for Bioanalytical Systems

NasdaqCM:BASI Ownership Summary, August 15th 2019
NasdaqCM:BASI Ownership Summary, August 15th 2019

What Does The Institutional Ownership Tell Us About Bioanalytical Systems?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

We can see that Bioanalytical Systems does have institutional investors; and they hold 6.1% of the stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone, since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Bioanalytical Systems's earnings history, below. Of course, the future is what really matters.

NasdaqCM:BASI Income Statement, August 15th 2019
NasdaqCM:BASI Income Statement, August 15th 2019

Hedge funds don't have many shares in Bioanalytical Systems. As far I can tell there isn't analyst coverage of the company, so it is probably flying under the radar.

Insider Ownership Of Bioanalytical Systems

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group.

It seems insiders own a significant proportion of Bioanalytical Systems, Inc.. Insiders own US$6.1m worth of shares in the US$22m company. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

General Public Ownership

The general public, who are mostly retail investors, collectively hold 60% of Bioanalytical Systems shares. This size of ownership gives retail investors collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions.

Private Company Ownership

Our data indicates that Private Companies hold 6.2%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.

Next Steps:

It's always worth thinking about the different groups who own shares in a company. But to understand Bioanalytical Systems better, we need to consider many other factors.

I always like to check for a history of revenue growth. You can too, by accessing this free chart of historic revenue and earnings in this detailed graph.

Of course this may not be the best stock to buy. Therefore, you may wish to see our free collection of interesting prospects boasting favorable financials.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.